LyphoMed Inc said the Food andDrug Administration gave it approval to market Vancomycin HCL,an antibiotic used in hospitals to treat life-threateninginfections.    It said the product is currently marketed by Eli Lilly andCo &lt;LLY> under the trade name Vancocin. Sales in 1986 were 110mln dlrs.    LyphoMed said its objective is to get a 15 to 20 pct shareof the market. Reuter&#3;